Fengsheng Dai

机构：Chongqing University, Chongqing Cancer Hospital · ORCID：0000-0002-4202-9173

发表论文 32 篇 · 总被引 542 次 · h-index 9

代表论文

• ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance (2022 · International Journal of Biological Sciences · 被引 63)
• KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7 (2022 · Scientific Reports · 被引 35)
• miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition (2021 · Molecular Therapy — Oncolytics · 被引 15)
• NTF4 plays a dual role in breast cancer in mammary tumorigenesis and metastatic progression (2023 · International Journal of Biological Sciences · 被引 11)
• PDCD2 as a prognostic biomarker in glioma correlates with malignant phenotype (2023 · Genes & Diseases · 被引 9)
• Comparison of the Pathological Complete Response Rate and Survival Between HER2-Low and HER2-Zero Breast Cancer in Neoadjuvant Chemotherapy Setting: A Systematic Review and Meta-Analysis (2024 · Clinical Breast Cancer · 被引 7)